Technical presentations included topics such as Drug Substance Freeze/Thaw Technology, SUT platforms for CAR-T manufacturing, end-to-end ROI modeling (stainless steel, hybrid, and full single-use mAb manufacturing platforms), considerations for facility design, and the advantages of SUT within multi-product/flexible facilities.

As SUT has become an emerging technology for biotech manufacturers, best practice sharing at forums such as ISPE has helped to rapidly advance knowledge and understanding between industry leaders and SUT suppliers.